Hit-to-lead drug development

/Hit-to-lead drug development
Hit-to-lead drug development 2020-06-25T11:27:59+00:00

Recepton’s integrated panel of drug discovery methods includes:

  • NMR fragment-based drug discovery
  • High throughput screening by HTRF
  • ELISA
  • AIDA-NMR
  • Cell-based assays
  • ADME